Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status
Tomoki Tamura, Takeshi Isobe, Haruyasu Murakami, Kosuke Hamai et al.
Citations
2 citations
Journal
Respiratory Investigation
Topics
Lung Cancer Treatments and Mutations
Field-Weighted Citation Impact (FWCI)
0.84
article
Comparison of efficacy of gefitinib and osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer in patients with poor performance status
Hamedan University of Medical Sciences (IR), Shimane University (JP), Shizuoka Cancer Center (JP), Hiroshima Prefectural Hospital (JP), Shimane Prefectural Central Hospital (JP), Iwakuni Medical Center (JP), Onomichi General Hospital (JP), Rehabilitation College Shimane (JP)